# Optima Health plc (OPT.L) fundamentals

Data as of 2026-11-04. LSE, United Kingdom. Sector: Healthcare / Health Care Technology. Price 246p, market value 268 millionp.

## Valuation
- **P/E (trailing): 123.0×** (5-yr avg 8999.9×, 3-yr avg 8999.9×). Optima Health plc trades at 123.0× trailing earnings, well below its own five-year average of 8999.9×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 13.8×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 24.3×**. Enterprise value is 24.3× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 4.5%** (5-yr avg 0.1%). Free cash flow equals 4.5% of the market value, above its five-year average of 0.1%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 0.8%**. The inverse of the P/E: 0.8% of the price is earned each year.

## Profitability
- **Gross margin: 29.3%**. Optima Health plc keeps 29.3% of revenue after the direct cost of what it sells.
- **Operating margin: 3.3%**. 3.3% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 1.2%**. 1.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 0.8%**. 0.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 0.8%**. Return on all capital, debt included, is 0.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 0.4%**. Each dollar of assets produces 0.4% of profit.

## Growth
- **Revenue growth (1 yr): 14.8%** (3-yr 1.5%/yr). Revenue grew 14.8% over the last year.
- **EPS growth (1 yr): -33.3%** (3-yr 3.7%/yr). Earnings per share fell 33.3%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 71.6%/yr**. Free cash flow has compounded at 71.6% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.74**. Debt is 0.74 times equity, moderate leverage.
- **Net debt / EBITDA: 6.8×**. It would take 6.8 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: 2.5×**. Operating profit covers interest 2.5×, thin but manageable.
- **Current ratio: 0.84** (quick 0.84). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.87**. A Z-score of 1.87 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Optima Health plc does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 25.3%** (YTD 23.1%, 3-mo -1.0%). The shares are up 25.3% over twelve months including dividends.
- **From 52-week high: -3.9%** (38.9% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 63**. An RSI of 63 is neutral.
- **Beta (1 yr): 0.05** (volatility 20%). Beta of 0.05 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OPT.L · Page: https://foliofundamentals.com/stocks/opt.l

Not investment advice.